1,532 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Acquired by GAMMA Investing LLC

GAMMA Investing LLC purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 1,532 shares of the company’s stock, valued at approximately $115,000.

Several other institutional investors and hedge funds have also bought and sold shares of HSIC. Linden Thomas Advisory Services LLC grew its position in shares of Henry Schein by 10.0% in the 4th quarter. Linden Thomas Advisory Services LLC now owns 8,345 shares of the company’s stock worth $632,000 after buying an additional 760 shares during the last quarter. Illinois Municipal Retirement Fund grew its position in shares of Henry Schein by 16.5% in the 4th quarter. Illinois Municipal Retirement Fund now owns 95,324 shares of the company’s stock worth $7,217,000 after buying an additional 13,482 shares during the last quarter. Wedge Capital Management L L P NC grew its position in shares of Henry Schein by 5.8% in the 4th quarter. Wedge Capital Management L L P NC now owns 471,419 shares of the company’s stock worth $35,691,000 after buying an additional 26,010 shares during the last quarter. Lee Danner & Bass Inc. grew its position in shares of Henry Schein by 7.1% in the 4th quarter. Lee Danner & Bass Inc. now owns 30,190 shares of the company’s stock worth $2,286,000 after buying an additional 2,010 shares during the last quarter. Finally, Duality Advisers LP bought a new stake in shares of Henry Schein in the 4th quarter worth approximately $1,561,000. 96.62% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. SVB Leerink assumed coverage on Henry Schein in a research note on Monday, February 26th. They issued a “market perform” rating and a $78.00 target price for the company. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. Piper Sandler raised their target price on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research note on Monday, February 26th. Finally, JPMorgan Chase & Co. raised their target price on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research note on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $81.09.

Henry Schein Stock Up 0.4 %

HSIC stock opened at $73.13 on Monday. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The business has a fifty day moving average price of $74.17 and a 200-day moving average price of $72.42. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. The stock has a market capitalization of $9.40 billion, a P/E ratio of 23.22, a P/E/G ratio of 1.81 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The business had revenue of $3.02 billion during the quarter, compared to analysts’ expectations of $3 billion. During the same quarter in the prior year, the firm earned $1.21 EPS. The firm’s revenue for the quarter was down 10.5% compared to the same quarter last year. Equities analysts forecast that Henry Schein, Inc. will post 5.07 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.